| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
REVENUE | ||||||
- | - | 0 | ||||
OPERATING EXPENSES | ||||||
General and administrative | ||||||
6,016 | 9,085 | 546 | ||||
Research and development | ||||||
3,281 | 3,354 | 435 | ||||
Gain on waiver of common stock issuable | ||||||
1,542 | - | - | ||||
Total operating expenses | ||||||
7,756 | 12,440 | 981 | ||||
LOSS FROM OPERATIONS | ||||||
-7,756 | -12,440 | -981 | ||||
OTHER INCOME | ||||||
Interest income | ||||||
77 | - | - | ||||
Other expense | ||||||
- | - | 0 | ||||
Gain on legal settlements | ||||||
- | - | 150 | ||||
Total other income | ||||||
77 | - | 149 | ||||
NET LOSS | ||||||
-7,678 | -12,440 | -831 | ||||
Net loss per common share - basic and diluted | ||||||
-0.75 | -1.43 | -0.13 | ||||
Weighted average number of common shares outstanding - basic and diluted | ||||||
10,272 | 8,676 | 6,564 | ||||
COMPREHENSIVE LOSS | ||||||
NET LOSS | ||||||
-7,678 | -12,440 | -831 | ||||
Other comprehensive loss - loss on foreign currency translation | ||||||
-15 | -25 | - | ||||
Other comprehensive loss - loss on foreign currency translation | ||||||
- | - | 34 | ||||
Total comprehensive loss | ||||||
-7,693 | -12,465 | -796 | ||||